Moncef Slaoui, former chief science officer for Operation Warp Speed, fired from the council on sexual harassment charges
GlaxoSmithKline rethinks the strategy for the Covid-19 antibody – not the Vir – after the test failed. Is there hope in high-risk patients? – News from Endpoints
Novavax, Inc. (NASDAQ: NVAX), GlaxoSmithKline PLC (NYSE: GSK) – Analyzing Novavax Coronavirus Vaccine Data: 2 Taken by Analyst
